Argenx Se ARGX
NASDAQ ARGX
$1,036.11 -17.35 (-1.65%)
As of: Sep 4, 2026 · 2:28 PM EDT

Argenx Se (ARGX) Other Operating Expenses (2019 - 2026)

Argenx Se's (ARGX) quarterly Other Operating Expenses came in at $387.0 million in Q2 2026, down 72.72% YoY from $1.4 billion in Q2 2025, and up 419.83% on a QoQ basis from -$121.0 million in Q1 2026.

Analysis

Argenx Se (ARGX) Other Operating Expenses (2019 - 2026) Analysis & Trends

Argenx Se (ARGX) has 8 years of Other Operating Expenses data on file, last reported at $387.0 million in Q2 2026.

  • Quarterly Other Operating Expenses fell 72.72% year-over-year to $387.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.6 billion (up 33.97% YoY) and the FY2025 annual result came in at $463.1 million, up 97.1% from the prior year.
  • Other Operating Expenses climbed to $387.0 million in Q2 2026, from -$121.0 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $1.5 billion in Q3 2025 to a low of -$153.2 million in Q4 2025.
  • A 5-year average of $142.2 million and a median of -$31.2 million in 2023 frame the typical range for Other Operating Expenses.
  • Annual changes were most pronounced in 2022 — Other Operating Expenses plunged 1346200.0% — and 2025, when it surged 2731.95%.
  • Tracing ARGX's Other Operating Expenses over 5 years: stood at -$13.5 million in 2022, then slumped by 206.51% to -$41.3 million in 2023, then tumbled by 81.77% to -$75.0 million in 2024, then tumbled by 104.27% to -$153.2 million in 2025, then jumped by 352.59% to $387.0 million in 2026.
  • The last three Other Operating Expenses figures came in at $387.0 million (Q2 2026), -$121.0 million (Q1 2026), and -$153.2 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn -
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn
10 Incyte 25.61 Bn 21.07 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -145.00 Mn
Mar 31, 2026 -121.00 Mn
Dec 31, 2025 -153.21 Mn
Sep 30, 2025 -113.20 Mn
Jun 30, 2025 -113.53 Mn
Mar 31, 2025 -81.00 Mn
Dec 31, 2024 -75.01 Mn
Sep 30, 2024 -61.05 Mn
Jun 30, 2024 -53.90 Mn
Mar 31, 2024 -44.97 Mn
Dec 31, 2023 -41.27 Mn
Sep 30, 2023 -36.74 Mn
Jun 30, 2023 -25.64 Mn
Mar 31, 2023 -18.60 Mn
Dec 31, 2022 -13.46 Mn
Sep 30, 2022 -10.26 Mn
Jun 30, 2022 -5.01 Mn
Mar 31, 2022 -1.37 Mn
Dec 31, 2021 -1,000.00
Sep 30, 2021 1,000.00